The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature

Chest

Volumn 127, Issue 6, 2005, Pages 1952-1959

  Sin, Don D ^a   Wu, LieLing ^b   Man, S F Paul ^b  

^a ST PAUL S HOSPITAL   (Canada)

^b NONE

Author keywords

Cardiovascular mortality; FEV1; Lung function; Metaanalysis; National Health and Nutrition Examination Survey

Indexed keywords

ADULT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SMOKING; SPIROMETRY; SYSTEMATIC REVIEW; AGE DISTRIBUTION; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; HOSPITALIZATION; LONGITUDINAL STUDY; LUNG DISEASE; LUNG FUNCTION TEST; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEX RATIO; SURVIVAL;

ADULT; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG DISEASES; MALE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SPIROMETRY; SURVIVAL ANALYSIS;

EID: 17244373523     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.6.1952     Document Type: Article

References (38)

1. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003; 114:758-762
2. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991; 133:795-800
3. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107:1514-1519
4. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1414-1418
5. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1179-1184
6. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002; 121(suppl):127S-130S
7. Yamanouchi H, Fujita J, Yoshinouchi T, et al. Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis. Respir Med 1998; 92:273-278
8. 1: the Lung Health Study. JAMA 1994; 272:1497-1505
9. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982; 248:1465-1477
10. Cox CS, Mussolino ME, Rothwell ST, et al. Plan and operation of the NHANES I Epidemiologic Follow-up Study, 1992. National Center for Health Statistics. Vital Health Stat 1 1997; 35:1-231
11. National Center for Health Statistics. Computer-assisted spirometry data analysis for the National Health and Nutrition Examination Survey, 1971-75. Washington, DC: US Government Printing Office, 1981
12. Hankinson JL, Odencrantz JR, Fedan KR. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179-187
13. Wilson PW, D'Agostino RR, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97:1837-1847
14. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Preventive Med 2001; 20(suppl):21-35
15. Khan K, Riet G, Popay J, et al. Study quality assessment: undertaking systematic reviews of research effectiveness; CRD's guidance for those carrying out or commissioning reviews. York, United Kingdom: NHS Centre for Reviews and Dissemination, 2001
16. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313:711-715
17. Higgins MW, Keller JB. Predictors of mortality in the adult population of Tecumseh. Arch Environ Health 1970; 21:418-424
18. Beaty TH, Newill CA, Cohen BH, et al. Effects of pulmonary function on mortality. J Chronic Dis 1985; 38:703-710
19. Marcus EB, Curb JD, MacLean CJ, et al. Pulmonary function as a predictor of coronary heart disease. Am J Epidemiol 1989; 129:97-104
20. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118:656-664
21. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol 1988; 41:251-260
22. Lange P, Nyboe J, Jensen G, et al. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J 1991; 4:1080-1087
23. Tockman MS, Comstock GW. Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland. Am Rev Respir Dis 1989; 140:S56-63
24. Krzyzanowski M, Wysocki M. The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study. Int J Epidemiol 1986; 15: 56-64
25. Hospers JJ, Rijcken B, Schouten JP, et al. Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. Am J Epidemiol 1999; 150:482-491
26. Kuller LH, Ockene JK, Townsend M, et al. The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial. Am Rev Respir Dis 1989; 140:S76-81
27. Speizer FE, Fay ME, Dockery DW, et al. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989; 140:S49-55
28. Kizer JR, Zisman DA, Blumenthal NP, et al. Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med 2004; 164:551-556
29. Engström G, Wollmer P, Hedblad B, et al. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914", Malmö, Sweden. Circulation 2001; 103:3086-3091
30. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a metaanalysis. Thorax 2004; 59:574-580
31. Guillen MI, Gomez-Lechon MJ, Nakamura T, et al. The hepatocyte growth factor regulates the synthesis of acute-phase proteins in human hepatocytes: divergent effect on interleukin-6-stimulated genes. Hepatology 1996; 23:1345-1352
32. Suwa T, Hogg JC, Quinlan KB, et al. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol 2002; 39:935-942
33. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109(suppl):II2-II10
34. Lloyd-Jones DM, Martin DO, Larson MG, et al. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 1998; 129:1020-1026
35. Coady SA, Sorlie PD, Cooper LS, et al. Validation of death certificate diagnosis for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Clin Epidemiol 2001; 54:40-50
36. Sutton AJ, Duval SJ, Tweedie RL, et al. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000; 320:1574-1577
37. Strachan DP. Ventilatory function, height, and mortality among lifelong non-smokers. J Epidemiol Commun Health 1992; 46:66-70
38. Curb JD, Marcus EB, Reed DM, et al. Smoking, pulmonary function, and mortality. Ann Epidemiol 1990; 1:25-32